Product Images Pregabalin

This is a graph showing the percentage of patients who experienced improvement in pain from baseline. The x-axis displays the dosage of Pregabalin in milligrams three times a day and the placebo. The y-axis shows the percentage of patients who experienced improvement, ranging from above 70% to 100%.*

This appears to be a chart or graph showing the percent of patients who experienced improvement in pain levels when taking Pregabalin 100 mg three times a day compared to a placebo. It is not possible to accurately interpret the data from the provided text.*

This is a chart that shows the efficacy of different doses of Pregabalin (a medication used for managing neuropathic pain) in improving pain levels in patients. The chart illustrates the percentage of patients whose pain levels improved after taking Pregabalin at different doses, as well as a placebo. However, there is no information on the duration or the condition for which the medication was used.*

This is a chart displaying the percentage of patients who reported improvement in pain from baseline while taking Pregabalin at different dosages or a placebo. The dosages listed are 100mg three times daily, 200mg three times daily, and a placebo. The percentages ranged from 0% to 100% improvement in pain.*

This is a clinical chart showing the percentage of patient improvement in pain from baseline, with comparisons between Pregabalin at 50mg and 100mg three times per day and placebo. The chart also displays a range from 0 to 100 percent and the corresponding percentage values in increments of 10.*

This is a table representing different study groups (E1 and E3) with different dosages of a particular medicine (50mg/day, 150mg/day, 300mg/day, and 600mg/day) and a placebo group. It provides the number of participants in each group and their percentage. No further information is available.*

The text describes a graph showing the percentage improvement in pain from baseline in patients taking different doses of pregabalin and a placebo. The percentages range from 0 to 100, and there is a noticeable increase in improvement with higher doses of pregabalin.*

The text indicates a chart showing the percentage of subjects improved over time, specifically from baseline to week 12, with values ranging from 210 to 290. The results compare the improvement percentage between two groups: Pregabalin and Placebo. The chart shows that both groups had 100% improvement.*

This data table shows the percentage of subjects who improved from baseline to week 16 in a clinical trial comparing a drug called Progateiin to a placebo. The drug appears to have a 100% improvement rate in the tested subjects.*

This is a description of Pregabalin 25mg capsules. The medication is packaged by Proficient Rx LP and contains 60 capsules per pack. Each capsule is imprinted with "SG" on the cap and "MASTER" on the body. The medication guide should be dispensed to each patient. The manufacturer is ScieGen Pharmaceuticals, Inc. The medication should be stored at 25°C (77°F) and kept out of the reach of children. The lot number is 00000 and the expiration date is 00/00/00.*